Respiratory syncytial virus (RSV) is associated with a considerable burden of hospitalizations, intensive care unit (ICU) ...

点击上方“感染学苑” 掌握感染疾病前沿动态9月26日，首都医科大学附属北京儿童医院、国家儿童医学中心、国家呼吸疾病临床研究中心、国家肿瘤监测中心倪鑫教授团队在《The New England Journal of ...

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

RSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...

NEW ALBANY, Miss. (WTVA) — Respiratory syncytial virus (RSV) is a big threat this time of year. RSV is a contagious virus ...

But there’s another virus out there that can also cause these symptoms: It’s called respiratory syncytial virus (RSV), and even if you’ve never heard of it before, there’s a very good ...

Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

On Tuesday, the FDA approved Pfizer Inc’s (NYSE:PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, to prevent lower respiratory tract ...